Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling.

Al-Zahrani, Khalid N; Cook, David P; Vanderhyden, Barbara C; Sabourin, Luc A

Al-Zahrani, Khalid N; Cook, David P; Vanderhyden, Barbara C; Sabourin, Luc A.

Afiliación

Al-Zahrani KN; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada.
Cook DP; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Vanderhyden BC; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada.
Sabourin LA; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Oncotarget ; 9(70): 33348-33359, 2018 Sep 07.

Article en En | MEDLINE | ID: mdl-30279965

Palabras clave

Sox10; androgen receptor; bioinformatics; biomarkers; breast cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google